文献

J-GLOBAL ID：201802244946273420   整理番号：18A1250353

The EAACI/GA2

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

著者 (49件)： Zuberbier T. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Dermatology and Allergy, Allergy-Centre-Charite, Berlin, Germany) ,  Aberer W. (Department of Dermatology, Medical University of Graz, Graz, Austria) ,  Asero R. (Department of Allergology, Clinica San Carlo, Paderno Dugnano, MI, Italy) ,  Abdul Latiff A. H. (Allergy& Immunology Centre, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia) ,  Baker D. (Baker Allergy Asthma and Dermatology Clinic, Portland, OR, USA) ,  Ballmer-Weber B. (Allergy Unit, Department of Dermatology, University Hospital, Zuerich, Switzerland) ,  Bernstein J. A. (University of Cincinnati Physicians Immunology Research Center, Cincinnati, OH, USA) ,  Bindslev-Jensen C. (Department of Dermatology and Allergy Centre, Odense University Hospital and University of Southern Denmark, Odense, Denmark) ,  Brzoza Z. (Department of Internal Diseases, Allergology and Clinical Immunology in Katowice, Medical University of Silesia, Katowice, Poland) ,  Buense Bedrikow R. (Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil) ,  Canonica G. W. (Personalized Medicine Asthma and Allergy Clinic-Humanitas University & Research Hospital, Milano, Italy) ,  Church M. K. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Dermatology and Allergy, Allergy-Centre-Charite, Berlin, Germany) ,  Craig T. (Department of Medicine and Pediatrics, Penn State University, Hershey Medical Center, Hershey, PA, USA) ,  Danilycheva I. V. (National Research Center-Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia) ,  Dressler C. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Division of Evidence Based Medicine, Department of Dermatology, Berlin, Germany) ,  Ensina L. F. (Federal University of Sao Paulo, Sao Paulo, Brazil) ,  Gimenez-Arnau A. (Hospital del Mar, IMIM, Universitat Autonoma Barcelona, Barcelona, Spain) ,  Godse K. (Department of Dermatology, Dr. D. Y. Patil Medical College & Hospital, Nerul, Navi Mumbai, India) ,  Goncalo M. (Clinic of Dermatology, Faculty of Medicine and University Hospital, Coimbra, Portugal) ,  Grattan C. (St John’s’ Institute of Dermatology, Guy’s’ and St. Thomas’ Hospital, NHS Foundation Trust, London, UK) ,  Hebert J. (Service d’allergie, Centre Hospitalier Universite Laval/Centre Hospitalier Universitaire de Quebec, Quebec, QC, Canada) ,  Hide M. (Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan) ,  Kaplan A. (Department of Medicine, Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, Charleston, SC, USA) ,  Kapp A. (Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany) ,  Katelaris C. H. (Campbelltown Hospital and Western Sydney University, Sydney, Australia) ,  Kocatuerk E. (Department of Dermatology, Okmeydani Training and Research Hospital, Istanbul, Turkey) ,  Kulthanan K. (Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand) ,  Larenas-Linnemann D. (Hospital Medica Sur, Mexico City, Mexico) ,  Leslie T. A. (Royal Free Hospital, London, UK) ,  Magerl M. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Dermatology and Allergy, Allergy-Centre-Charite, Berlin, Germany) ,  Mathelier-Fusade P. (Department of Dermatology and Allergy, University Hospital of Tenon, Paris, France) ,  Meshkova R. Y. (Department of Clinical Immunology and Allergy, Smolensk State Medical University, Smolensk, Russia) ,  Metz M. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Dermatology and Allergy, Allergy-Centre-Charite, Berlin, Germany) ,  Nast A. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Division of Evidence Based Medicine, Department of Dermatology, Berlin, Germany) ,  Nettis E. (Scuola e Cattedra di Allergologia e Immunologia Clinica, Dipartimento dell’Emergenza e dei Trapianti d’Organo, Universita di Bari, Bari, Italy) ,  Oude-Elberink H. (University of Groningen, Groningen, The Netherlands) ,  Rosumeck S. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Division of Evidence Based Medicine, Department of Dermatology, Berlin, Germany) ,  Saini S. S. (Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA) ,  Sanchez-Borges M. (Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela) ,  Schmid-Grendelmeier P. (Allergy Unit, Department of Dermatology, University Hospital, Zuerich, Switzerland) ,  Staubach P. (Department of Dermatology, University Medical Center Mainz, Mainz, Germany) ,  Sussman G. (Division of Allergy and Clinical Immunology, University of Toronto, Toronto, ON, Canada) ,  Toubi E. (Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel) ,  Vena G. A. (Dermatology and Venereology Private Practice, Bari and Barletta, Italy) ,  Vestergaard C. (Department of Dermatology and Venereology, Aarhus University Hospital, Aarhus, Denmark) ,  Wedi B. (Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany) ,  Werner R. N. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Division of Evidence Based Medicine, Department of Dermatology, Berlin, Germany) ,  Zhao Z. (Department of Dermatology and Venereology, Peking University, First Hospital, Beijing, China) ,  Maurer M. (Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Dermatology and Allergy, Allergy-Centre-Charite, Berlin, Germany)
資料名： Allergy  (Allergy)
巻： 73  号： 7  ページ： 1393-1414  発行年： 2018年 
JST資料番号： E0643B  ISSN： 0105-4538  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： この証拠と合意に基づくガイドラインは,Cochraneによって推奨された方法と勧告評価,開発と評価(GRADE)作業グループの等級付けに従って開発された。会議は2016年12月1日に開催された。それは,ヨーロッパのアレルギー学会と臨床免疫学(EAACI),EU設立ネットワーク,世界的アレルギーと喘息ヨーロッパネットワーク(GA2LEN),欧州皮膚科学フォーラム(EDF)と世界アレルギー機関(WAO)の共同イニシアティブである。42の国家と国際社会の48のdelegatesの参加を伴う。このガイドラインは,欧州連合(UEMS)の欧州連合によって認識され,受け入れられた。じん麻疹は高頻度の肥満細胞駆動疾患で,whe,血管浮腫,または両者を呈する。急性じん麻疹の生涯有病率は約20%である。慢性自然じん麻疹とじん麻疹の他の慢性型は,障害があり,生活の質を損ない,仕事と学校でのパフォーマンスに影響する。このガイドラインは,その原因,誘発因子および病理学的機構の同定における最近の進歩を考慮して,じん麻疹の定義と分類をカバーする。加えて,じん麻疹の異なるサブタイプに対する証拠に基づく診断および治療アプローチを概説した。Copyright 2018 Wiley Publishing Japan K.K. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 喘息 ,  ネットワーク ,  皮膚科学 ,  *蕁麻疹 ,  等級づけ ,  ヨーロッパ ,  クオリティオブライフ ,  罹患率 ,  アレルギー反応 ,  欧州連合 ,  肥満細胞 ,  治療法 ,  病理学
準シソーラス用語： 急性蕁麻疹 ,  血管性浮腫 , 【Automatic Indexing@JST】

著者キーワード (5件)： 血管浮腫 ,  コンセンサス ,  証拠ベース ,  HIVE ,  whe

分類 (3件)： 免疫性疾患・アレルギー性疾患一般  (GD04010C) ,  皮膚の疾患  (GF03000Q) ,  皮膚疾患の薬物療法  (GF05020A)